ACCP - Store - IDSAP 2023 Book 2 Global Public Health Issues

IDSAP 2023 Book 2 Global Public Health Issues

Member Price:
$80.00

Nonmember Price:
$120.00

ASHP members, please call (913)492-3311 to receive member pricing. Your ASHP membership number and expiration date are required.

Multi-book Discounts Available!

In the latest release from the Infectious Diseases Self-Assessment Program (IDSAP), experienced practitioners and scholars review the management of common infectious syndromes that are frequently experienced in settings around the world with an emphasis on issues faced in low- and middle- income countries (LMIC).

The target audience for Global Public Health Issues is board-certified infectious diseases pharmacists caring for adult or pediatric patients in acute and/or ambulatory settings around the world.

Faculty Panel Chair Rakhi Karwa, Pharm.D., BCPS — Karwa

Global Public Health Issues contains four learning modules with a total available 17.0 continuing pharmacy education (CPE) credits. Book content was developed under the leadership of Faculty Panel Chairs Rakhi Karwa, Pharm.D., BCPS; and Sonak Pastakia, Pharm.D., MPH, Ph.D., FCCP.

Faculty Panel Chair Sonak Pastakia, Pharm.D., MPH, Ph.D., FCCP — Pastakia

The first module focuses on the latest updates regarding the management of commonly encountered parasitic illnesses and malaria. This module also provides guidance on travel medicine to inform global health practitioners, ambulatory care providers and readers who travel frequently about the strategies they should take to minimize their risk of contracting and spreading illnesses while traveling abroad. The second module focuses on providing guidance on managing tuberculosis and resistance in both high burden and low burden countries. It also discusses the unique dynamics of managing antimicrobial stewardship programs and addressing resistance in LMIC settings. In module three, the response to HIV in LMIC settings is reviewed along with a discussion of health equity in infectious diseases. The final module includes an interactive case on the complexity of managing anti-TB therapy in patients experiencing hepatoxicity and a webcast on the unique supply chain dynamics found in LMICs.

Each IDSAP release has continuing education activities that cover the most recent published data (past 3-5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

Traditional review-style chapters
Interactive cases (a series of webpages, each introduced by a sample case-based question)
Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

All IDSAP chapters and features are fully referenced,

Release Date: November 15, 2023
BCIDP Deadline: May 15, 2024

ACPE Deadline: November 15, 2026

ISBN: 978-1-952291-87-6
Publication Year: 2023
Format: PDF and ePub
Number of Pages: 200

MORE PRODUCTS IN THIS SERIES

Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCIDP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.

IDSAP 2023 Book 2 Global Public Health Issues

CPE Credit

Commercial Support

Cookies